Shanooja Shanavas
University Road, Derlakatte
Mangalore, KA 575018, India
Mangalore, KA 575018, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Turning Off the Powerhouse: Mitochondria-Targeted DPPZ-Ru(II)/Ir(III)/Re(I) Complexes Trigger Dual Mitophagy and Apoptosis To Halt Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: February 02, 2026
Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231.
Journal: Journal of medicinal chemistry
Published: December 07, 2025
Targeting GSK-3β to Modulate the Wnt Pathway: A Promising Neuroprotective Strategy for Alzheimer's Disease.
Journal: Molecular pharmaceutics
Published: October 15, 2025
The role of ancillary ligands on benzodipyridophenazine-based Ru(II)/Ir(III) complexes in dark and light toxicity against TNBC cells.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: February 25, 2025
Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment.
Journal: Journal of medicinal chemistry
Published: February 05, 2025
Sialic Acid-Targeted Ru(II)/Ir(III)/Re(I) Complexes for Ferroptosis Induction in Triple-Negative Breast Cancer.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: November 18, 2024
Effective Targeting of Colorectal Cancer Stem Cells by Inducing Differentiation Mediated by Low-Dose Vitamin C via β-Catenin Retention in the Cell Membrane.
Journal: Journal of cellular biochemistry
Published: July 11, 2024
2-Aryl-1H-imidazo[4,5-f][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic Agents.
Journal: Journal of medicinal chemistry
Published: May 30, 2024
Mitigation of chronic glucotoxicity-mediated skeletal muscle atrophy by arachidonic acid.
Journal: Life sciences
Published: August 13, 2023
Luminescent 11-{Naphthalen-1-yl}dipyrido[3,2-a:2',3'-c]phenazine-Based Ru(II)/Ir(III)/Re(I) Complexes for HCT-116 Colorectal Cancer Stem Cell Therapy.
Journal: ACS applied bio materials
Published: January 13, 2023
Iridium(III)-Cp*-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem cell therapeutic agents.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: March 16, 2022
Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468.
Journal: RSC advances
Published: February 16, 2022
Last Updated: 09/26/2026